Click Therapeutics, Inc. — SEC Form D Filing
Click Therapeutics, Inc. filed an SEC Form D on October 1, 2026, reporting $50.00M raised in Other Health Care.
Form D filing details
- Filing
- SEC Form D
- Filing date
- October 1, 2026
- Amount reported
- $50.00M
- Round stage
- Growth because raising approximately $50 million in equity indicates a mature, clinical-stage company scaling its commercial partnerships and FDA clearance pipeline.
- Industry
- Other Health Care
- Website
- https://www.clicktherapeutics.com
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Patients suffering from chronic psychiatric and neurological conditions lack accessible, clinically validated, and non-invasive treatment options to supplement traditional pharmaceutical therapies.
Solution
Click Therapeutics develops and commercializes FDA-regulated prescription digital therapeutics delivered through mobile applications that utilize cognitive, behavioral, and neuromodulatory approaches to treat medical conditions.
Why now
The convergence of widespread smartphone adoption, established regulatory pathways for software-as-a-medical-device, and increasing clinical acceptance of digital health interventions has created a massive opportunity for prescription software.
Source: SEC EDGAR Form D filing